Detalhe da pesquisa
1.
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
Acta Oncol
; 60(11): 1543-1547, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355650